Global Targeted RNA Sequencing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Targeted RNA Sequencing market size will reach 3,492.11 Million USD in 2025 and is projected to reach 13,919.29 Million USD by 2032, with a CAGR of 21.84% (2025-2032). Notably, the China Targeted RNA Sequencing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Targeted RNA sequencing is a technique used to selectively sequence specific RNA molecules of interest from a complex mixture of RNA samples. Unlike whole transcriptome sequencing, which sequences all RNA molecules present in a sample, targeted RNA sequencing focuses on particular RNA transcripts or gene regions. This approach allows researchers to analyze the expression levels of specific genes or RNA variants with higher sensitivity and depth compared to whole transcriptome sequencing. Targeted RNA sequencing involves the design and use of custom probes or primers that selectively capture and amplify the RNA targets of interest before sequencing. This technique is widely used in research areas such as gene expression analysis, biomarker discovery, and investigating RNA splice variants or fusion genes implicated in diseases such as cancer. Targeted RNA sequencing offers advantages such as increased throughput, reduced sequencing costs, and improved detection sensitivity for low-abundance RNA molecules, making it a valuable tool for studying gene expression profiles in diverse biological samples.

The major global suppliers of Targeted RNA Sequencing include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Targeted RNA Sequencing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Targeted RNA Sequencing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Targeted RNA Sequencing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Targeted RNA Sequencing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Targeted RNA Sequencing Include:

Thermo Fisher

Illumina

Roche Holdings

BGI

Eurofins

LabCorp

Berry Genomics

Macrogen

GENEWIZ

Targeted RNA Sequencing Product Segment Include:

Exome Sequencing

Enrichment Sequencing

Amplicon Sequencing

Targeted RNA Sequencing Product Application Include:

Research Institutes

Hospitals & Clinics

Biotechnology Company

Diagnostic Lab

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Targeted RNA Sequencing Industry PESTEL Analysis

Chapter 3: Global Targeted RNA Sequencing Industry Porter's Five Forces Analysis

Chapter 4: Global Targeted RNA Sequencing Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Targeted RNA Sequencing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Targeted RNA Sequencing Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Targeted RNA Sequencing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources